Creative Planning »

Zentalis Pharmaceuticals shares owned by Creative Planning

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Creative Planning from 13F filings

Historical chart of Creative Planning investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Creative Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Creative Planning

Quarter filed Position value Share count Share price at filing
2024-03-31 $183k 12k 15.76
2023-12-31 $167k 11k 15.15

More positions owned by Creative Planning

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Core Msci Emkt (IEMG)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Vanguard Index Fds Real Estate Etf (VNQ)
Ishares Tr National Mun Etf (MUB)

View all positions for Creative Planning

Top funds holding Zentalis Pharmaceuticals

Eventide Asset Management
FMR
BlackRock
Vanguard Group
Citadel Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
Federated Investors
Decheng Capital
MPM Oncology Impact Management
Woodline Partners
Geode Capital Management
Verition Fund Management
Morgan Stanley
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals